메뉴 건너뛰기




Volumn 45, Issue 8, 2005, Pages 910-918

A phase I multiple-dose escalation study characterizing pharmacokinetics and safety of ABT-578 in healthy subjects

Author keywords

ABT 578; Multiple dose; Pharmacokinetics; Safety

Indexed keywords

ABT 578; PLACEBO; RAPAMYCIN; RAPAMYCIN DERIVATIVE;

EID: 23044441336     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270005278807     Document Type: Article
Times cited : (10)

References (20)
  • 1
    • 0035306941 scopus 로고    scopus 로고
    • Clinical trials of vascular brachytherapy for in-stent restenosis: Update
    • Ajani AE, Kim HS, Waksman R. Clinical trials of vascular brachytherapy for in-stent restenosis: update. Cardiovasc Radiat Med. 2001;2:107-113.
    • (2001) Cardiovasc Radiat Med , vol.2 , pp. 107-113
    • Ajani, A.E.1    Kim, H.S.2    Waksman, R.3
  • 2
    • 0034008545 scopus 로고    scopus 로고
    • Restenosis after percutaneous coronary intervention and infection
    • Herzum M, Schaefer JR, Simon B, Menz V, Noll B, Maisch B. Restenosis after percutaneous coronary intervention and infection. Herz. 2000;25:91-94.
    • (2000) Herz , vol.25 , pp. 91-94
    • Herzum, M.1    Schaefer, J.R.2    Simon, B.3    Menz, V.4    Noll, B.5    Maisch, B.6
  • 3
    • 0027934377 scopus 로고
    • A randomized comparison of coronary-stent replacement and balloon angioplasty in the treatment of coronary artery disease
    • Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent replacement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
    • (1994) N Engl J Med , vol.331 , pp. 496-501
    • Fischman, D.L.1    Leon, M.B.2    Baim, D.S.3
  • 4
    • 0028123099 scopus 로고
    • A comparison of the balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
    • Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of the balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
    • (1994) N Engl J Med , vol.331 , pp. 489-495
    • Serruys, P.W.1    De Jaegere, P.2    Kiemeneij, F.3
  • 5
    • 0032480946 scopus 로고    scopus 로고
    • Coronary artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty
    • Erbel R, Haude M, Hopp HW, et al. Coronary artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med. 1998;339:1672-1678.
    • (1998) N Engl J Med , vol.339 , pp. 1672-1678
    • Erbel, R.1    Haude, M.2    Hopp, H.W.3
  • 6
    • 0037180418 scopus 로고    scopus 로고
    • Coated stents for the prevention of restenosis
    • Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis. Circulation. 2002;106:2859-2866.
    • (2002) Circulation , vol.106 , pp. 2859-2866
    • Babapulle, M.N.1    Eisenberg, M.J.2
  • 7
    • 0141765805 scopus 로고    scopus 로고
    • Sirolimus-eluting stents verses standard stents in patients with stenosis in a native coronary artery
    • Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents verses standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
    • (2003) N Engl J Med , vol.349 , pp. 1315-1323
    • Moses, J.W.1    Leon, M.B.2    Popma, J.J.3
  • 8
    • 0038299000 scopus 로고    scopus 로고
    • Sirolimus: Its discovery, biological properties and mechanism of action
    • Sehgal SN. Sirolimus: its discovery, biological properties and mechanism of action. Transplant Proc. 2003;35(suppl 1):7S-14S.
    • (2003) Transplant Proc , vol.35 , Issue.SUPPL. 1
    • Sehgal, S.N.1
  • 9
    • 0032105481 scopus 로고    scopus 로고
    • Rapammume (RAPA, sirolimus): Mechanism of action. Immunosuppressive effects results from blockade if signal transduction and inhibition of cell cycle progression
    • Sehgal SN. Rapammume (RAPA, sirolimus): mechanism of action. Immunosuppressive effects results from blockade if signal transduction and inhibition of cell cycle progression. Clin Biochem. 1998;31:335-340.
    • (1998) Clin Biochem , vol.31 , pp. 335-340
    • Sehgal, S.N.1
  • 12
    • 33444473224 scopus 로고    scopus 로고
    • ABT-578, paclitaxel, and rapamycin-eluting stents show similar efficacy in a porcine model of coronary restenosis. Poster presented; March; Washington, DC
    • Burke SE, Toner JL, Cromack KR, et al. ABT-578, paclitaxel, and rapamycin-eluting stents show similar efficacy in a porcine model of coronary restenosis. Poster presented at: Annual Meeting of Cardiovascular Revascularization Therapies (CRT); March 2005; Washington, DC.
    • (2005) Annual Meeting of Cardiovascular Revascularization Therapies (CRT)
    • Burke, S.E.1    Toner, J.L.2    Cromack, K.R.3
  • 13
    • 2042441795 scopus 로고    scopus 로고
    • 96-Well liquid-liquid extraction liquid chromatography-tandem mass spectrometry method for the quantitative determination of ABT-578 in human blood samples
    • Ji QC, Reimer TM, El-Shourbagy TA. 96-Well liquid-liquid extraction liquid chromatography-tandem mass spectrometry method for the quantitative determination of ABT-578 in human blood samples. J. Chromatogr B. 2004;805:67-75.
    • (2004) J. Chromatogr B , vol.805 , pp. 67-75
    • Ji, Q.C.1    Reimer, T.M.2    El-Shourbagy, T.A.3
  • 16
    • 33444475085 scopus 로고    scopus 로고
    • Safety and pharniacokinetics of single, escalating, intravenous doses of ABT-578 in healthy male subjects
    • Palaparthy R, Pradhan RS, Chan J, et al. Safety and pharniacokinetics of single, escalating, intravenous doses of ABT-578 in healthy male subjects [abstract]. AAPS J. 2004;6:M1096.
    • (2004) AAPS J , vol.6
    • Palaparthy, R.1    Pradhan, R.S.2    Chan, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.